MAGGIOLINI, Marcello
 Distribuzione geografica
Continente #
NA - Nord America 8.934
EU - Europa 6.911
AS - Asia 1.093
AF - Africa 321
Continente sconosciuto - Info sul continente non disponibili 19
OC - Oceania 19
SA - Sud America 14
Totale 17.311
Nazione #
US - Stati Uniti d'America 8.701
UA - Ucraina 2.289
DE - Germania 1.282
RU - Federazione Russa 967
SE - Svezia 682
AT - Austria 669
IT - Italia 598
CN - Cina 394
SN - Senegal 318
TR - Turchia 303
CA - Canada 229
IN - India 191
FI - Finlandia 133
FR - Francia 72
GB - Regno Unito 71
HK - Hong Kong 61
BE - Belgio 56
KR - Corea 56
NL - Olanda 53
SG - Singapore 27
AU - Australia 19
EU - Europa 19
IR - Iran 19
VN - Vietnam 16
IE - Irlanda 9
JP - Giappone 7
RO - Romania 6
BR - Brasile 5
SA - Arabia Saudita 5
CH - Svizzera 3
EC - Ecuador 3
LV - Lettonia 3
PE - Perù 3
AL - Albania 2
BD - Bangladesh 2
BG - Bulgaria 2
ES - Italia 2
IL - Israele 2
KG - Kirghizistan 2
KW - Kuwait 2
LT - Lituania 2
PL - Polonia 2
AR - Argentina 1
BA - Bosnia-Erzegovina 1
BO - Bolivia 1
BY - Bielorussia 1
CL - Cile 1
EE - Estonia 1
EG - Egitto 1
GT - Guatemala 1
HU - Ungheria 1
IQ - Iraq 1
JM - Giamaica 1
KH - Cambogia 1
KZ - Kazakistan 1
LA - Repubblica Popolare Democratica del Laos 1
LU - Lussemburgo 1
MK - Macedonia 1
MS - Montserrat 1
MX - Messico 1
PH - Filippine 1
PT - Portogallo 1
SK - Slovacchia (Repubblica Slovacca) 1
TN - Tunisia 1
TW - Taiwan 1
ZA - Sudafrica 1
Totale 17.311
Città #
Chandler 1.657
Jacksonville 1.370
Moscow 965
San Mateo 840
Dearborn 663
Vienna 463
New York 354
Dakar 318
Lawrence 306
Roxbury 306
Ashburn 299
Izmir 276
Des Moines 199
Ottawa 186
Ann Arbor 166
Rende 163
Brooklyn 142
Inglewood 137
Shanghai 136
Helsinki 133
Grafing 125
Beijing 112
Wilmington 103
Bremen 97
Ogden 94
Cambridge 93
Florence 85
Seattle 65
Seoul 56
Hong Kong 50
Brussels 47
Houston 38
San Francisco 37
Pune 36
Toronto 36
Redwood City 35
Leawood 27
Bari 24
Boardman 23
Norwalk 23
Flensburg 21
Los Angeles 21
Monmouth Junction 21
Bangalore 18
Jinan 18
Redmond 17
Falls Church 16
Ho Chi Minh City 16
Nanjing 15
Cosenza 14
Kilburn 14
Singapore 13
Ardabil 12
Rome 12
Augusta 11
Hefei 10
Iesi 10
London 10
Ningbo 10
Amantea 9
Hanover 9
Messina 9
Dublin 8
Edinburgh 8
Haikou 8
Kunming 8
Melbourne 8
Palermo 8
Woodbridge 8
Amsterdam 7
Changsha 7
Frankfurt am Main 7
Hangzhou 7
Mons 7
Zhengzhou 7
Berlin 6
Central 6
Chennai 6
Gunzenhausen 6
Hebei 6
Lanzhou 6
Milan 6
Nanchang 6
Paris 6
Shenyang 6
Sydney 6
Tokyo 6
Buffalo 5
Canberra 5
Carovigno 5
Mumbai 5
Portoferraio 5
Riyadh 5
Tappahannock 5
Barnsley 4
Catanzaro 4
Chicago 4
Fuzhou 4
Groningen 4
Jiaxing 4
Totale 10.820
Nome #
c-Jun activation is required for 4-hydroxytamoxifen-induced cell death in breast cancer cells 1.025
Crystallographic snapshots of host–guest interactions in drugs@metal–organic frameworks: towards mimicking molecular recognition processes 128
(6-Bromo-1,4-dimethyl-9H-carbazol-3-yl-methylene)-hydrazine (Carbhydraz) Acts as a GPER Agonist in Breast Cancer Cells 119
Functional characterization of the partially purified Sac1p-independent adenine nucleotide transport system (ANTS) from yeast endoplasmic reticulum 108
GPER Mediates a Feedforward FGF2/FGFR1 Paracrine Activation Coupling CAFs to Cancer Cells Toward Breast Tumor Progression 108
Focal adhesion kinase (FAK) activation by estrogens involves GPER in triple-negative breast cancer cells 104
17beta-estradiol, genistein, and 4-hydroxytamoxifen induce the proliferation of thyroid cancer cells through the g protein-coupled receptor GPR30 103
Copper activates HIF-1α/GPER/VEGF signalling in cancer cells 99
GPER, IGF-IR, and EGFR transduction signaling are involved in stimulatory effects of zinc in breast cancer cells and cancer-associated fibroblasts 99
Assunzione di calcio e massa ossea in Italia: risultati preliminari di uno studio multicentrico europeo (CALEUR). 98
AHR and GPER mediate the stimulatory effects induced by 3-methylcholanthrene in breast cancer cells and cancer-associated fibroblasts (CAFs) 98
17 beta -Estradiol, Genistein and 4-Hydroxytamoxifen induce proliferative effects in thyroid cancer cells via G protein couplet-receptor GPR30. 96
Cyclooxygenase (Cox)-2 regulating transcriptional and post-transcriptional activation of aromatase is involved in Leydig cell tumor proliferation 92
Androgen receptor activation inhibits the genomic effect of estradiol in MCF7 cells, a molecular basis of its antiproliferatie action 91
17beta-estradiol modulation of male rat cardiac performance: inotropism and mechanism of action 91
Computational Approaches for the Discovery of GPER Targeting Compounds 91
Estrogenic GPER signaling regulates mir144 expression in cancer cells and cancer-associated fibroblasts (CAFs) 90
GPER activation mitigates cardiotoxicity induced by the anticancer agent doxorubicin 90
Bisphenol A Induces Gene Expression Changes and Proliferative Effects through GPER in Breast Cancer Cells and Cancer-Associated Fibroblasts 89
Bergapten antagonizes cell survival and induces p53 gene promoter together with p38 MAPK activation in breast cancer cells 89
Bone mineral density is inversely related to parathyroid hormone in adolescent girls 87
E-cadherin mediates the aggregation of breast cancer cells induced by tamoxifen and epidermal growth factor 87
Epidermal growth factor induces G protein-coupled receptor 30 expression in estrogen receptor-negative breast cancer cells 85
Carbazole derivatives as potential novel agonist of GPER 85
The G protein-coupled receptor GPR30 mediates c-fos up-regulation by 17beta-estradiol and phytoestrogens in breast cancer cells 85
Androgen role in breast cancer. 84
A novel VNTR enhancer within the SIRT3 gene, a human homologue of SIR2, is associated with survival at oldest ages 83
Apoptosis of breast cancer cells induced by lauric acid occours through p21Cip/WAF1 in a p53 independent manner 83
GPER Mediates Non-Genomic Effects of Estrogen 82
Isoliquiritigenina: nuovo approccio sintetico e sue proprieta’ estrogeniche e citotossiche 81
17beta- estradiol, genistein and 4-hydroxytamoxifen induce the proliferation of thyroid cancer cells through the G protein coupled – receptor GPR30. 80
Crosstalk between Notch, HIF-1α and GPER in breast cancer EMT 80
miR-221 stimulates breast cancer cells and cancer-associated fibroblasts (CAFs) through selective interference with the A20/c-Rel/CTGF signaling 80
In vitro antiproliferative and proapoptotic activities of 2-oxazolidinone derivatives 80
17β-estradiol modulation of male rat cardiac performance: inotropism and mechanism of action 79
Correlazioni fra alterazioni dell'ecosistema vaginale e comparsa di candidosi vaginali. 79
17β-estradiol enhances α(5) integrin subunit gene expression through ERα-Sp1 interaction and reduces cell motility and invasion of ERα-positive breast cancer cells 79
17beta estradiol induces negative lusitropic effect in the male rat heart 78
Estrogen receptor alpha mediates the estrogenic but not the antiproliferative dose-dependent effects of isoliquiritigenin in MCF-7 breast cancer cells 78
A calixpyrrole derivative acts as an antagonist to GPER, a G-protein coupled receptor: mechanisms and models. 78
miR-338-3p Is Regulated by Estrogens through GPER in Breast Cancer Cells and Cancer-Associated Fibroblasts (CAFs) 78
Leptin induces, via ERK1/ERK2 signal, functional activation of estrogen receptor alpha in MCF-7 cells 77
Differential expression of estrogen receptors (ERalpha/ERbeta) in testis of mature and immature pigs 77
Aromatase overexpression enhances the stimulatory effects of adrenal androgens on MCF7 breast cancer cells 77
ERK docking sites mediate the differential capacity of c-Jun and JunD to respond to ERK-signaling 77
Identification of two benzopyrroloxazines acting as selective GPER antagonists in breast cancer cells and cancer-associated fibroblasts 76
A time course study on the "in vitro" effect of T3 and Testosterone on androgen and estrogen receptors in peripuberal rat Sertoli cells. 76
Aromatase overexpression enhances the stimulatory effects of androgens on MCF7 breast cancer cells. 76
Composition, Antifungal and Antiproliferative Activities of the Hydrodistilled Oils from Leaves and Flower Heads of Pterocephalus nestorianus Nab. 75
A membrane G protein-coupled receptor (GPR30) mediates the cardiac effects of 17â-estradiol in the male rat 75
17 beta-estradiol, genestein and 4-hydroxytamixifen induce proliferative effects in thyroid cancer cells via G protein coupled-receptor GPR30 74
Bergapten inducing proteasome-dependent degradation of estrogen receptor alpha may overcome breast cancer tamoxifen-resistance 74
17beta-estradiolo activates rapid signaling pathways involved in rat pachytene spermatocytes apoptosis through GPR30 and ERalpha 73
Effect of oestradiol and insulin on proliferative pattern and on oestrogen and progesterone receptor contents in MCF-7 cells 72
A new role of leptin as amplifier of estrogen signaling in breast cancer. 72
The Food Contaminants Bisphenol A and 4-Nonylpheno act as agonist for Estrogen Receptor α in MCF7 Breast Cancer Cells 72
Differential MicroRNA Landscape Triggered by Estrogens in Cancer Associated Fibroblasts (CAFs) of Primary and Metastatic Breast Tumors 72
17 β-estradiol activates GPER- and ESR1-dependent pathways inducing apoptosis in GC-2 cells, a mouse spermatocytes-derived cell line. 72
Focal Adhesion Kinase Fine Tunes Multifaced Signals toward Breast Cancer Progression 72
Androgen receptor activation inhibits the genomic effect of estradiol in MCF-7 cells. A molecular basis of its antiproliferative action 70
Estrogenic Gper-signaling triggers RERG expression in breast cancer cells and cancer-associated fibroblasts 70
G protein-coupled receptor 30 (GPR30) mediates gene expression changes and growth response to 17beta-estradiol and selective GPR30 ligand G-1 in ovarian cancer cells 70
Critical years and stages of puberty for radial bone mass apposition during adolescence 70
Different Biological Effects of Chenodeoxycholic acid (CDCA) in Endometrial Cancer 69
Identification of novel estrogen-regulated microRNAs in breast tumor cells and cancer-associated fibroblasts (CAFS) 69
The lauric acid-activated signaling prompts apoptosis in cancer cells 69
Protective role of GPER Agonist G-1 on cardiotoxicity induced by doxorubicin 68
GPER mediates activation of HIF1α/VEGF signaling by estrogens 68
Differential phosphorylation of c-Jun and JunD in response to the epidermal growth factor is determined by the structure of MAPK targeting sequences 67
The effect of dietary calcium intake on bone mineral density in healthy adolescent girls and young women in Southern Italy 67
HIF-1α/GPER signaling mediates the expression of VEGF induced by hypoxia in breast cancer associated fibroblasts (CAFs) 67
Azione di GABA e melatonina sui recettori della somatostatina in alcune aree telencefaliche di ratti in età e condizioni gonadali differenti 67
A Biocompatible Aspartic-Decorated Metal-Organic Framework with Tubular Motif Degradable under Physiological Conditions 67
The evaluation of androgen circulating levels following castration in adult male rats 66
Nuovi ligandi di recettori estrogenici accoppiati a proteina G 66
Notch1 mediates preconditioning protection induced by GPER in normotensive and hypertensive female rat hearts 66
A cross-talk between the androgen receptor and the epidermal growth factor receptor leads to p38MAPK-dependent activation of mTOR and cyclinD1 expression in prostate and lung cancer cells 66
Oestrogen receptor beta is required for androgen-stimulated proliferation of LNCaP prostate cancer cells 65
The red wine phenolics piceatannol and myricetin act as agonists for estrogen receptor alpha in human breast cancer cells 65
GPER activation mitigates cardiotoxicity induced by the anticancer agent doxorubicin 65
The G Protein-Coupled Estrogen Receptor (GPER) Expression Correlates with Pro-Metastatic Pathways in ER-Negative Breast Cancer: A Bioinformatics Analysis 65
Estrogen Receptors and Chronic Venous Disease. 64
Distinct configurations of ERK docking sites mediate the differential capacity of c-Jun and JunD to sense the duration of ERK-signalling 64
Activation of the s100a7/rage pathway by igf-1 contributes to angiogenesis in breast cancer 64
S100A4 Is Involved in Stimulatory Effects Elicited by the FGF2/FGFR1 Signaling Pathway in Triple-Negative Breast Cancer (TNBC) Cells 64
Antiestrogens ICI 182,780 and 4-hydroxytamoxifen upregulate Erb expression and inhibit human adrenocortical cancer proliferation. 63
The Peptide ERα17p Is a GPER Inverse Agonist that Exerts Antiproliferative Effects in Breast Cancer Cells 63
Cancer associated fibroblasts: role in breast cancer and potential as therapeutic targets 63
Menin uncouples Elk-1, JunD and c-Jun phosphorylation from MAP kinase activation 62
Epididymal and sex accessory gland secretions in transfusion-dependent beta-thalassemic patients: evidence of an impaired prostatic function 62
G protein-coupled estrogen receptor mediates the up-regulation of fatty acid synthase induced by 17β-estradiol in cancer cells and cancer-associated fibroblasts 61
GPER mediates cardiotropic effects in Spontaneously Hypertensive Rat hearts 61
GPER is involved in the stimulatory effects of aldosterone in breast cancer cells and breast tumor-derived endothelial cells 61
Different Biological Effects of Chenodeoxycholic acid (CDCA)in Endometrial Cancer 61
GPER is involved in the regulation of the estrogen-metabolizing CYP1B1 enzyme in breast cancer 61
17β-Estradiol activates GPER- and ESR1-dependent pathways inducing apoptosis in GC-2 cells, a mouse spermatocyte-derived cell line 61
SIRT1 is involved in oncogenic signaling mediated by GPER in breast cancer 60
Bisfenolo A e 4-nonilfenolo nei vegetali destinati all’alimentazione umana 60
Valutazione del livelli di fruttosio,fosfatasi acida e zinco nello eiaculato con varicocele primitivo 60
Epidermal growth factor up-regulates SLC37A1 gene expression in cancer cells 60
Totale 8.615
Categoria #
all - tutte 98.030
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 98.030


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2018/2019311 0 0 0 0 0 0 0 0 0 22 279 10
2019/20202.888 293 286 9 305 181 697 205 325 71 62 311 143
2020/20212.644 361 26 291 318 29 309 49 359 248 305 98 251
2021/20223.938 59 587 26 339 373 155 33 923 35 44 525 839
2022/20234.127 580 544 160 542 522 338 23 514 458 96 189 161
2023/20243.025 331 128 196 69 144 720 469 518 235 215 0 0
Totale 17.652